Thirumalai Chemicals Limited

As of June 30, 2026, Thirumalai Chemicals Limited carries a market capitalization of 20.11B, placing it among publicly traded companies globally. Its enterprise value stands at 20.11B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Thirumalai Chemicals Limited has 120.55M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Thirumalai Chemicals Limited trades at an EV/EBITDA multiple of 167.33 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.10 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 20.11B versus a market cap of 20.11B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 20.73M in revenue per employee across its workforce of 884.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Thirumalai Chemicals Limited recorded an income tax benefit of -249.00M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -1.77B and -1.52B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Thirumalai Chemicals Limited's stock has declined approximately 57.20% over the past 52 weeks. The 50-day moving average sits at 151.89, while the 200-day moving average is 179.07.

Over the twelve months ended June 30, 2026, Thirumalai Chemicals Limited generated 18.32B in revenue and converted that into -1.52B in net income, yielding earnings per share of -12.94. EBITDA reached 120.20M, while operating income came in at -697.10M.

Over the twelve months ended June 30, 2026, Thirumalai Chemicals Limited posted a gross margin of 23.20, reflecting its pricing power and cost economics. The operating margin of -3.80 and net profit margin of -8.28 provide insight into operational efficiency.

Thirumalai Chemicals Limited's most recent stock split took place on August 14, 2018 with a 1:10 split ratio.